Life sciences Life sciences Lonza invests CHF 650 million in a new large-scale production facility in Visp 10 May 2021
Life sciences Berna Biotech Pharma and Swiss Biotech Center to develop second-generation covid-19 vaccine 5 May 2021
Life sciences ADC Therapeutics receives FDA approval for its lymphoma cancer treatment ZYNLONTA 28 April 2021
Life sciences Life sciences Lonza invests CHF 200 million in a new production facility in Visp 27 April 2021
Life sciences Calcification propensity diagnostics start-up Calciscon raises CHF 2.5 million 19 April 2021
Life sciences Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp 12 April 2021